PFE — Pfizer
Data coverage, completeness and provenance for Pfizer in the Stock Market API — Health Care · Drug Manufacturers - General.
Stored price coverage
Source date: 2026-11-19T21:01:31. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 27.5400 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 28.0600 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 28.4700 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 28.8600 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 28.8900 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/PFE/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Employees: 75,000 · Website: https://www.pfizer.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/PFE/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-31 | 31 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-31 | 31 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 31 | sec_edgar | ||||
| FY2022 (USD) | 2022-12-31 | 31 | sec_edgar | ||||
| FY2021 (USD) | 2021-12-31 | 31 | sec_edgar |
Get PFE data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/PFE
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/PFE/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/PFE/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/PFE/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/PFE
Query PFE programmatically
Free tier — instant API key. Built for AI agents.
Other NYSE · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for PFE?
- Stored coverage for PFE: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/PFE; inspect available source metadata for provenance.
- How complete is PFE's financial data?
- The anchor reporting period (FY2025) has 94.1% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for PFE?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/PFE/financials.
- Where does PFE's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/PFE/financials; missing tags do not establish provenance.